Bioethics, Ltd.
BOTH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,717 | $1,362 | $295 | $2,157 |
| - Cash | $15 | $0 | $0 | $1 |
| + Debt | $586 | $443 | $421 | $395 |
| Enterprise Value | $2,288 | $1,805 | $715 | $2,552 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$123 | $0 | -$47 | -$59 |
| % Margin | – | – | – | – |
| Net Income | -$177 | -$97 | -$93 | -$107 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.12 | -0.086 | -0.082 | -0.094 |
| % Growth | -40.2% | -4.3% | 13% | – |
| Operating Cash Flow | -$150 | -$22 | -$26 | -$27 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$150 | -$22 | -$26 | -$27 |